A Safety and Efficacy Trial Evaluating the Use of Apixaban in the Treatment of Symptomatic Deep Vein Thrombosis and Pulmonary Embolism
A Safety and Efficacy Trial Evaluating the Use of Apixaban in the Treatment of Symptomatic Deep Vein Thrombosis and Pulmonary Embolism
The purpose of this study is to evaluate the effects of an investigational blood thinner, apixaban, in preventing venous thromboembolic (VTE) recurrence or death in patients with deep vein thrombosis (DVT) or pulmonary embolism (PE)
Inclusion Criteria:
Exclusion Criteria:
New Haven, Connecticut 06510, United States
Washington D.C., District of Columbia 20037, United States
Buenos Aires, Buenos Aires C1280AEB, Argentina
Ciudad Autonoma de Buenos Aire, Buenos Aires C1180AAX, Argentina
Belo Horizonte - Mg, Minas Gerais 30150, Brazil
Rio Janeiro, Rio de Janeiro 22280, Brazil
Port Alegre, Rio Grande do Sul 90020, Brazil
Shengyang, Liaoning 110004, China
Ostrava Vitkovice, 703 84, Czechia
Arhus C, 8000, Denmark
Hilleroed, 3400, Denmark
Karlsbad, 76307, Germany
Pokfulman, XXXXX, Hong Kong
Hyderabad, Andhra Pradesh 500 082, India
Hyderabad, Andhra Pradesh 500034, India
Bioemfontein, Free State 9301, South Africa